CRISPR Therapeutics
CRSP
CRSP
35 hedge funds and large institutions have $211M invested in CRISPR Therapeutics in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 9 closing their positions.
Holders
35
Holders Change
+9
Holders Change %
+34.62%
% of All Funds
0.87%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
18
Increased
5
Reduced
3
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$1.74M |
2 |
PC
2
Paulson & Co
New York
|
$1.1M |
3 |
3
Morgan Stanley
New York
|
$447K |
4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$150K |
5 |
IWM
5
IHT Wealth Management
Chicago,
Illinois
|
$110K |